Top 5 Drug And Device Developments Of 2016

By Christine Kain, Patrick Reilly and Joseph Price, Faegre Baker Daniels LLP (January 9, 2017, 3:54 PM EST) -- Christine Kain

Patrick Reilly

Joseph Price As we begin the New Year, we reflect on some of 2016's most significant legal developments for our drug and device clients. The year saw many big lawsuits and jury decisions, but key developments occurred in the underpinning civil procedure, with potential widespread impact for future litigation. Here is a brief recap and assessment of the implications for five of the most significant developments in 2016.

Fifth Circuit Affirms Video Testimony in J&J Hip MDL

The Fifth Circuit's [re]affirmation of Judge Kinkeade's blanket order in the Johnson & Johnson hip MDL, allowing plaintiffs to use...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!